Inflammatory Bowel Diseases
Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders characterized by chronic relapsing inflammation of the gastrointestinal tract that affect 0.1% of Western populations, comprising two major forms, Crohn's disease (CD) and ulcerative colitis (UC). Adjuvants to the traditional therapy of inflammatory bowel disease (IBD) have been studied to enhance the efficacy of the treatment and improve patients’ quality of life. Approximately 1.6 million Americans currently have IBD, a growth of about 200,000 since the last time CCFA reported in 2011. As many as 70,000 new cases of IBD are diagnosed in the United States each year. There may be as many as 80,000 children in the United States with IBD.
Related Conference of Inflammatory Bowel Diseases
September 29-30, 2025
7th International Conference on Gastroenterology and Liver Diseases
Paris, France
October 20-21, 2025
24th International Conference on Gastroenterology and Digestive Disorders
Osaka, Japan
January 19-20, 2026
26th International Conference on Gastroenterology and Hepatology
Vienna, Austria
April 20-21, 2026
20th World Congress on Gastroenterology -Therapeutics & Hepatology
Barcelona, Spain
May 21-22, 2026
17th International Conference on Liver Diseases & Hepatology
Aix-en-Provence, France
Inflammatory Bowel Diseases Conference Speakers
Recommended Sessions
- Advancements in Hepatology
- Clinical Innovations in Gastroenterology
- Core Gastroenterology and Hepatology
- Endoscopy
- Gastrointestinal cancers and Liver Diseases
- Gastrointestinal Diseases during Pregnancy and Lactation
- Gastrointestinal Immunology
- Gastrointestinal Surgery
- GI Bleeding and Pathology
- Inflammatory Bowel Diseases
- Neurogastroenterology and Motility
- Pancreatic and Biliary Diseases
- Pediatric Gastroenterology, Hepatology and Nutrition
- Therapeutic and Diagnostic Gastroenterology
- Tracking trends in Gastroenterology
Related Journals
Are you interested in
- Advances in Gastrointestinal Oncology - WORLD GASTROENTEROLOGY 2026 (Spain)
- Advances in GERD Treatment - WORLD GASTROENTEROLOGY 2026 (Spain)
- Alcoholic Liver Disease: Emerging Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Barrett’s Esophagus: Current Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Celiac Disease: Latest Treatment Options - WORLD GASTROENTEROLOGY 2026 (Spain)
- Diagnostic Biomarkers and Therapeutic Targets in Digestive Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Digestive System Cancers - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Emerging Therapies for Crohn's - WORLD GASTROENTEROLOGY 2026 (Spain)
- Endoscopy and Minimally Invasive Gastrointestinal Procedures - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Esophageal Disorders: Current Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Gastrointestinal Disorders and Treatment - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Infections and Immunity - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology and Tumor Biology - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Stromal Tumors: Novel Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Gut Microbiota and Gastrointestinal Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gut Microbiota and Metabolic Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Hepatic Encephalopathy: Modern Management Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatitis C Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatocellular Carcinoma: Latest Approaches - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatology: Liver Disease and Transplantation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Disease and Intestinal Inflammation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Innovations in IBD Management - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver and Pancreatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Cirrhosis: New Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver Diseases and Hepatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Microbiome and Gastrointestinal Health - WORLD GASTROENTEROLOGY 2026 (Spain)
- NAFLD and NASH Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- New Approaches to Peptic Ulcer Disease - WORLD GASTROENTEROLOGY 2026 (Spain)
- Non-Alcoholic Fatty Liver Disease - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Nutrition and Aging: Geriatric Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pancreatitis: Modern Therapeutic Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Pediatric and Adolescent Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology and Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Peptic Ulcer and Acid-related Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Plant-Based Nutrition and Sustainable Diets - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Role of Microbiota in Digestive Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Therapeutics for Biliary Diseases - WORLD GASTROENTEROLOGY 2026 (Spain)
- Ulcerative Colitis: Innovative Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Viral Hepatitis: New Treatment Paradigms - WORLD GASTROENTEROLOGY 2026 (Spain)